- Off Label Use of Eltrombopag and Recombinant Activated Factor VII in Wiskott-Aldrich Syndrome. A Case Report and Review of Literature
-
Adramerina A, Chainoglou N, Theodoridou S, Teli A, Economou M
- KMID: 2529685
- Clin Pediatr Hematol Oncol.
- 2022 Apr;29(1):12-16.
- doi: 10.15264/cpho.2022.29.1.12
Wiskott-Aldrich syndrome (WAS) is characterized by eczema, recurrent infections and microthrombocytopenia, with the latter being the most consistent finding in the course of the disease. The present case report describes... -
- CITED
-
- Close
- SHARE
-
- Close
